ASN
RLAY icon

Advisory Services Network’s Relay Therapeutics RLAY Stock Holding History

Advisory Services Network’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.9K Buy
+1,697
New +$15.2K ﹤0.01% 3289
2025
Q4 		– Sell
-81
Closed -$423 – 3741
2025
Q3 		$423 Buy
+81
New +$309 ﹤0.01% 4077

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Advisory Services Network's RLAY Position: Q1 2026 in Review

Advisory Services Network opened a new position in Relay Therapeutics (RLAY) in Q1 2026: 1,697 shares worth $16.9K. The stake represents ﹤0.01% of the portfolio and ranks #3289 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in RLAY as recently as Q3 2025.

Advisory Services Network first reported a position in RLAY in Q3 2025 and has held it in 2 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Advisory Services Network held 1,697 shares of Relay Therapeutics worth $16.9K as of Q1 2026.
  • Relay Therapeutics was a new Advisory Services Network position in Q1 2026.
  • Relay Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3289 holding.
  • Advisory Services Network first reported a position in Relay Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.